Research · Sep 3, 2026
[OPLN] Owens Minor Patient Direct Apria Thesis 2026: Home Health Spin Off Compounder
Owens & Minor Patient Direct/Apria (NASDAQ: OPLN, formerly Apria-Inc), is a Patient-Direct-Apria-Home-Health-and-Healthcare-Services + emerging-multi-cycle-Patient-Direct-Apria-Spin-Off-from-Owens-Minor leader providing distinctive multi-cycle Apria-Home-Health-Sleep-and-Respiratory-Therapy + emerging-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-and-BiPAP-Cycle + emerging-Home-Oxygen-and-Respiratory-Therapy + emerging-Diabetes-Direct-Home-Delivery + emerging-Home-Negative-Pressure-Wound-Therapy services to substantial multi-cycle Home-Sleep-Apnea-CPAP-and-BiPAP-Patient + multi-cycle-emerging-Home-Oxygen-and-Respiratory-Therapy-Patient + multi-cycle-emerging-Diabetes-Direct-Home-Delivery-Patient + multi-cycle-emerging-Home-Negative-Pressure-Wound-Therapy-Patient + multi-cycle-emerging-Medicare-and-Medicaid-and-Commercial-Insurance-Payor customer base. The company has distinctive multi-cycle Owens-Minor-Patient-Direct-Apria-and-Patient-Direct-Home-Health heritage: founded 1979 as Apria-Home-Health-Pioneer + 1995-Apria-Healthcare-historical + 2008-Apria-Healthcare-Acquired-Blackstone-Take-Private + 2018-Apria-Healthcare-IPO-NASDAQ-Re-Listing-Post-Blackstone + 2021-Apria-Owens-Minor-Acquired-Owens-Minor-Reverse-Morris-Trust-like + 2024-Owens-Minor-Patient-Direct-Apria-Spin-Off-Process-Initiated + Multi-Cycle-Patient-Direct-Strategic-Review-and-Spin-Off + 2024-2025-Spin-Off-Process-Owens-Minor-Patient-Direct-Apria-Spin-Off-Anticipated-2025-2026 + Multi-Cycle-Patient-Direct-Home-Healthcare-Services-Pure-Play-Strategy; multi-cycle-disciplined-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Capital-Management; Patient-Direct-CEO-Post-Spin-Off-Owens-Minor + Multi-Cycle-Owens-Minor-Patient-Direct-Apria-Capital-Management leadership-continuity. FY2025 closes with selected various aggregate revenue ~$2.55-2.85B (~3-8% YoY-reflecting Patient-Direct-Apria-Home-Health-Cycle + emerging-multi-cycle-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle), adjusted EBITDA ~$285-345M (~10-12% margins), adjusted EPS ~$0.85-1.30, net debt ~$1.10-1.40B (~3.5-4.5x leverage), and ~75-78M shares outstanding under Patient-Direct-Apria-Post-Spin-Off-Leadership. The Apria-Home-Health-Sleep-and-Respiratory-Therapy-and-Patient-Direct-Services franchise deep-dive covers distinctive multi-cycle ~7,000-7,500 employees + ~Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Operating-Footprint across US-National, Home-Sleep-Apnea-CPAP-and-BiPAP-and-Respiratory-Therapy ~58-65% revenue + Diabetes-Direct-and-Home-Negative-Pressure-Wound-Therapy ~22-28% revenue + Other-Home-Healthcare-Services-Adjacency ~10-15% revenue, substantial multi-cycle Home-Sleep-Apnea-CPAP-and-BiPAP-Patient + Home-Oxygen-and-Respiratory-Therapy-Patient + Diabetes-Direct-Home-Delivery-Patient + Home-Negative-Pressure-Wound-Therapy-Patient + Medicare-and-Medicaid-and-Commercial-Insurance-Payor customer base, 1979-Apria-Home-Health-Pioneer + 2018-Apria-IPO-NASDAQ-Re-Listing + 2021-Apria-Owens-Minor-Acquired + 2024-Spin-Off-Process-Initiated transformational-platform, emerging-multi-cycle Patient-Direct-Apria-Spin-Off-from-Owens-Minor + emerging-Home-Sleep-Apnea-CPAP-and-Respiratory-Therapy-Cycle + emerging-Patient-Direct-Home-Healthcare-Services + emerging-Home-Sleep-Apnea-CPAP-Recurring-Resupply-Cycle + emerging-Diabetes-Direct-Home-Delivery-Cycle + emerging-Conservative-Debt-Paydown-Post-Spin-Off structural-tailwinds, competing in Patient-Direct-Apria-Home-Health space with AdaptHealth, Lincare Holdings-Linde, Aerogen, Quipt Home Medical, VieMed Healthcare, Insulet, Dexcom, Tandem Diabetes Care, CCS Medical-AdaptHealth-acquired, Edgepark Medical Supplies-Cardinal-Health. The Patient-Direct-Apria-Post-Spin-Off-Leadership + 2024-Spin-Off-Process + 1979-Apria-Home-Health-Founded-and-2018-Apria-NASDAQ-Re-Listing-and-2021-Owens-Minor-Acquired-and-2024-Spin-Off-Process deep-dive covers Patient-Direct-Apria-Post-Spin-Off-Leadership + multi-cycle-Owens-Minor-Patient-Direct-Apria-Capital-Management leadership-continuity expertise, multi-cycle-disciplined-Patient-Direct-Apria-Home-Health-and-Healthcare-Services-Capital-Management discipline, no-dividend (Cash-Flow-Reinvested-in-Patient-Direct-Apria-Home-Health-and-Conservative-Debt-Paydown-Post-Spin-Off) + multi-cycle-emerging-share-buyback-Post-Spin-Off-discretionary. Capital position is Sub-IG (Ba2/BB to Ba1/BB+ ~3.5-4.5x leverage). At ~$14-22 per share, equity value ~$1.05-1.70B, EV ~$2.15-3.10B, providing ~11-19x EPS and ~7-10x EV/EBITDA.